This story was first published in digitalhealth.net
Funding available for SMEs to develop medical innovations
Small and medium sized enterprises (SMEs) can apply for a share of £1.5 million to help evaluate medical devices in real-world clinical settings.
The competition aims to provide evidence to support SMEs developing medical technologies and solutions to be commissioned by the NHS.
This follows research from the 2016 Accelerated Access Review which shows that SMEs often face obstacles in presenting real-world evidence – within an NHS setting – to support their efforts to get their products commissioned within the NHS.
Up to £1.5 million is available in a competition through Innovate UK and the Office for Life Sciences to support evaluating devices, diagnostics and digital technologies in a real-world clinical setting.
Projects should have a product that aligns with at least one NHS priority healthcare area, as detailed in the NHS Long Term Plan.
Priority will be given to projects related to ageing well; cancer; digital transformation; learning disabilities and autism; mental health; personalised care; and prevention.
The competition will open on 22 April 2019, and close at midday on 3 July 2019.
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
